Baillie Gifford - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,821,474
-58.7%
88,507
-5.6%
0.00%
-50.0%
Q2 2023$4,406,667
+10.5%
93,719
-1.4%
0.00%0.0%
Q1 2023$3,988,088
+10.2%
95,045
+0.2%
0.00%0.0%
Q4 2022$3,618,913
+1.1%
94,885
+3.8%
0.00%0.0%
Q3 2022$3,580,000
+25.3%
91,395
+3.3%
0.00%
+33.3%
Q2 2022$2,857,000
-12.6%
88,446
-10.4%
0.00%
+50.0%
Q1 2022$3,269,000
-15.0%
98,766
+9.3%
0.00%0.0%
Q4 2021$3,845,000
+0.5%
90,372
+4.7%
0.00%0.0%
Q3 2021$3,824,000
-16.1%
86,298
+7.5%
0.00%0.0%
Q2 2021$4,559,000
-12.7%
80,265
+15.1%
0.00%
-33.3%
Q1 2021$5,221,000
+83.3%
69,749
+111.9%
0.00%
+50.0%
Q4 2020$2,848,000
+173.6%
32,916
+93.3%
0.00%
+100.0%
Q3 2020$1,041,000
+1477.3%
17,030
+971.1%
0.00%
Q2 2020$66,000
+164.0%
1,590
+80.9%
0.00%
Q1 2020$25,000
-28.6%
879
+79.4%
0.00%
Q4 2019$35,000
-49.3%
4900.0%0.00%
Q3 2019$69,0004900.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders